Red Light Holland Corp (TRUFF) Fair Value & Analysis
Healthcare · US · Market cap $11.9M
Red Light Holland Corp
TRUFF · US
Fair value as of: Jul 31, 2026
From 1 valuation models · updated 11 days ago
Fair value updated Jul 31, 2026, revised from $0.0200 to $0.0208 (+4.0%) since Jun 26, 2026. Share price +32.3% over the past month.
Below-average quality, and screening another 17% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case ($0.0229). The favourable scenario is already priced in.
- Weak quality (37/100) and above fair value at the same time, the margin of safety is missing on both counts.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 31, 2026.
How to read this chart
60‑month range $0.0110 – $0.3100 · fair‑value band $0.0187 – $0.0229 · the $0.0250 price screens above the $0.0208 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 31, 2026.
Analysis
Red Light Holland Corp (TRUFF) currently trades at $0.0250, while our model-based Fair Value estimate is $0.0208, implying the stock looks roughly 16.8% overvalued today. The Quality Score stands at 37/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at $4.2M. Revenue grew 8.2% year over year. It earns a return on equity of -31.4%. The balance sheet holds a net cash position of $16.7M. Fundamentals as of Jul 31, 2026
Our scenario range runs from $0.0187 (bear case) to $0.0229 (bull case); at $0.0250, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 48% below its 52-week high and 178% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -49% fair-value upside, at -17%, TRUFF screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 1 models by family
Notify me when TRUFF reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 31, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 38 · Market factors (momentum, volatility) 38
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Red Light Holland Corp. engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe.
Full company description
Red Light Holland Corp. engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe. The company is also involved in the selection, distribution, and export of truffles, cannabidiol products, cannabis seeds, headshop products, growshop goods, cannabis bake house muffins, cookies, and cakes. It sells its products under the iMicrodose, Maka, Happy Caps, and Mistercap's brands through brick-and-mortar SmartShops, as well as through online stores. Red Light Holland Corp. is based in Toronto, Canada.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Red Light Holland Corp reported revenue of $4.9M in FY2025 versus $111K in FY2021, a compound +158.4%/yr. Reported net income was −$4.0M in FY2025.
TRUFF screens 17% overvalued. Compare with Jiangsu Hengrui Pharmaceuticals Co →
Peer Group
Drug Manufacturers - Specialty & Generic · 623 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jul 31, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥53.19 | ¥25.94 | -51% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,933 | ₹989.50 | -49% |
| Divi's Laboratories Limited DIVISLAB | ₹7,316 | ₹1,943 | -73% |
| Torrent Pharmaceuticals Limited TORNTPHARM | ₹4,763 | ₹1,329 | -72% |
| PharmaEssentia Corporation 6446 | 1,285 TWD | 221.01 TWD | -83% |
| Cipla Limited CIPLA | ₹1,439 | ₹1,001 | -30% |
| Zydus Lifesciences Limited ZYDUSLIFE | ₹1,151 | ₹703.32 | -39% |
| Lupin Limited LUPIN | ₹2,443 | ₹2,477 | +1% |
| Mankind Pharma Limited MANKIND | ₹2,484 | ₹983.11 | -60% |
| Dr. Reddy's Laboratories Limited DRREDDY | ₹1,211 | ₹874.79 | -28% |
Compare Red Light Holland Corp with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Red Light Holland Corp (TRUFF) overvalued or undervalued?
What is the fair value of TRUFF?
What is the quality score of TRUFF?
What is the revenue of Red Light Holland Corp (TRUFF)?
What is the net profit margin of TRUFF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Red Light Holland Corp and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.